Fairfield, Bush & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Sell |
6,015
-16
| -0.3% | -$2.97K | 0.63% | 45 |
|
|
2025
Q1 | $1.26M | Sell |
6,031
-218
| -3% | -$45.7K | 0.8% | 37 |
|
|
2024
Q4 | $1.11M | Buy |
6,249
+2,739
| +78% | +$487K | 0.65% | 44 |
|
|
2024
Q3 | $693K | Buy |
3,510
+335
| +11% | +$66.2K | 0.41% | 63 |
|
|
2024
Q2 | $545K | Sell |
3,175
-943
| -23% | -$162K | 0.33% | 61 |
|
|
2024
Q1 | $750K | Sell |
4,118
-773
| -16% | -$141K | 0.44% | 57 |
|
|
2023
Q4 | $758K | Sell |
4,891
-388
| -7% | -$60.1K | 0.44% | 55 |
|
|
2023
Q3 | $787K | Sell |
5,279
-198
| -4% | -$29.5K | 0.51% | 50 |
|
|
2023
Q2 | $738K | Sell |
5,477
-222
| -4% | -$29.9K | 0.2% | 89 |
|
|
2023
Q1 | $908K | Sell |
5,699
-923
| -14% | -$147K | 0.32% | 71 |
|
|
2022
Q4 | $1.07M | Sell |
6,622
-48
| -0.7% | -$7.76K | 0.71% | 39 |
|
|
2022
Q3 | $895K | Buy |
6,670
+834
| +14% | +$112K | 0.63% | 42 |
|
|
2022
Q2 | $894K | Sell |
5,836
-2,868
| -33% | -$439K | 0.53% | 46 |
|
|
2022
Q1 | $1.41M | Sell |
8,704
-667
| -7% | -$108K | 0.71% | 36 |
|
|
2021
Q4 | $1.27M | Buy |
9,371
+972
| +12% | +$132K | 0.61% | 42 |
|
|
2021
Q3 | $906K | Buy |
8,399
+2,435
| +41% | +$263K | 0.29% | 75 |
|
|
2021
Q2 | $671K | Buy |
5,964
+400
| +7% | +$45K | 0.18% | 96 |
|
|
2021
Q1 | $602K | Sell |
5,564
-501
| -8% | -$54.2K | 0.17% | 106 |
|
|
2020
Q4 | $650K | Buy |
6,065
+2,125
| +54% | +$228K | 0.19% | 97 |
|
|
2020
Q3 | $345K | Buy |
+3,940
| New | +$345K | 0.11% | 114 |
|
|
2018
Q2 | – | Sell |
-1,540
| Closed | -$146K | – | 158 |
|
|
2018
Q1 | $146K | Buy |
+1,540
| New | +$146K | 0.04% | 157 |
|